NCT05487092 - Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian Cystectomy | Biotech Hunter

Enrollment

194

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Endometriotic Cyst of Ovary

Interventions

DRUG

Letrozole

Letrozole 2.5mg daily for 6 months

OTHER

Placebo

Trial Locations (5)

RECRUITING

Queen Mary Hospital, Hong Kong

NOT_YET_RECRUITING

Kwong Wah Hospital, Hong Kong

NOT_YET_RECRUITING

Pamela Youde Nethersole Eastern Hospital, Hong Kong

NOT_YET_RECRUITING

Princess Margaret Hospital, Hong Kong

NOT_YET_RECRUITING

Queen Elizabeth Hospital, Hong Kong

All Listed Sponsors

collaborator

Pamela Youde Nethersole Eastern Hospital

OTHER

collaborator

The Queen Elizabeth Hospital

OTHER

collaborator

Kwong Wah Hospital

OTHER

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

The University of Hong Kong

OTHER